Skip to main content
Caplight Logo









AMILI

AMILI

Private
SingaporeHealthcare & Life Scienceshttps://amili.asia/

Last Round

Series A

Extension

May 29, 2023

Total Funding Raised

$10.5M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

AMILI is a biotechnology company that provides gut microbiome data insights, analytics, tests, and therapeutics, and operates Southeast Asia's first gut microbiome transplant bank.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

gut microbiome testingprecision nutritionmicrobiome databioinformaticsmicrobiome sequencinggut healthpersonalized healthAI nutritionbiobankFMTfecal microbiota transplantclinical diagnosticshealth-techat-home testingbiohacker

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AMILI Comparables

Compare AMILI with similar companies based on industry and business-model similarity.

AMILI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GenieBiome
81%
Leucine Rich Bio
81%
Biome Diagnostics
77%

AMILI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMay 29, 2023
Series AJun 15, 2022

Key People

Founding team and executive leadership

Jeremy Lim

Chief Executive Officer

Executive Team

Manu Swarup

Chief Operating Officer

Executive Team

AMILI Investors

Notable investors and investment history

AMILI investors
InvestorRounds
G. K. Goh Holdings Pte. Ltd.Series A
Capital CodeSeries A
SEEDS CapitalSeries A
Blue7Series A
Vulcan CapitalSeries A
East VenturesSeries A Extension
Elang Mahkota TeknologiSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 119% MoM, from 6.1K to 13.4K.

  • Feb 10, 2026

    Developing a precise nutrition program in collaboration with Google.

AMILI Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AMILI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AMILI's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore
Employee Range59
Year Founded2019
Last FundingMay 29, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?